IHS Chemical Week

Regions :: Western Europe :: Sweden

Pfizer Opens Biotech Plant in Sweden

4:00 AM MDT | August 27, 2009 | Deepti Ramesh

Pfizer says it has opened a previously announced new facility for biotechnological pharmaceutical production at Strangnas, Sweden. Pfizer expects the plant, which was built with an investment of about €150 million ($213 million), to further strengthen its capacities in the rapidly growing biotech sector. The plant is Sweden’s largest site for the production of biotechnological pharmaceuticals, Pfizer says. “Biologics hold tremendous promise in changing the way patients are treated and diseases prevented,” says Rory O’Connor...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa